Biotechnology - , Ontario, Canada
A clinical stage company developing a novel treatment for CTCL, a type of skin cancer which afflicts 100,000 new patients annually. Our R&D is based on a combined effort of Professor Hinanit Koltai, head of medical cannabis research at the national lab in ARO, Israel together with Professor Emmilia Hodek, director of Dermatology, Rabin Medical Center, Israel.Our R&D pipeline includes 2 additional skin oncology indications and anxiety related indications. Head Office in Toronto, CanadaR&D in Israel
Gmail
Varnish
Facebook Login (Connect)
Mobile Friendly
Google Cloud Hosting